Delivery Order SPE2DR25D6048-SPE2DR26FAQQ1
- Not listed
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,109.75 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL units). The contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $12,393.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL in quantities of 10 units, with an ultimate completion date of December 29, 2025. This non-set-aside contract was competitively awarded on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for atropine 1 mg/10 ml syringes with a firm fixed price ceiling value of $1,738.67. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $4,213.36 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/ml vial supplies, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,046.81 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Atropine 1 mg/mL vials. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of July 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,397.77 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 25, 2025. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,994.02 and an ultimate completion date of July 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under...
- This federal contract award with a ceiling value of $13,325.25 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of Atropine 1mg/1ml in quantities of 25 syringes, with an ultimate completion date of October 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this firm fixed-price delivery order contract to supply this critical drug product to...
- SPE2DR25D6048Indefinite Delivery Contract
- SPE2DR25D6048-SPE2DR26FAQQ1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,312.85 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL). The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was competitively awarded with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen is a major pharmaceutical distributor that supplies critical medical commodities across multiple therapeutic domains to federal agencies, particularly military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies. This specific delivery order for atropine—an emergency medication used to treat nerve agent exposure and other medical emergencies—reflects the company's role in ensuring the availability of essential pharmaceutical products for military readiness and medical preparedness operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/11/26 |